This announcement is a separate document:
盘龙药业：中泰证券股份有限公司关于陕西盘龙药业集团股份有限公司2023年度持续督导定期现场检查报告
Shaanxi Panlong Pharmaceutical: Zhongtai Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Shaanxi Panlong Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.